{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:00:19Z","timestamp":1790672419292,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T00:00:00Z","timestamp":1490140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Wroclaw Centre of Biotechnology"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jneuroim.2017.02.006","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T11:00:42Z","timestamp":1486638042000},"page":"115-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS"],"prefix":"10.1016","volume":"305","author":[{"given":"Edyta","family":"Pawlak-Adamska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Karabon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pokryszko-Dragan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Partyka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tomkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Ptaszkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Frydecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"Podemski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw","family":"Dybko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Bilinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jneuroim.2017.02.006_bb0005","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1464-5491.2007.02297.x","article-title":"Diabetes incidence in Sweden study group. No evidence of association of the PDCD1 gene with type 1 diabetes","volume":"24","author":"Asad","year":"2007","journal-title":"Diabet. Med."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0010","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1464-5491.2007.02297.x","article-title":"Diabetes incidence in Sweden study group. No evidence of association of the PDCD1 gene with type 1 diabetes","volume":"24","author":"Asad","year":"2007","journal-title":"Diabet. Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2017.02.006_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1352458511417480","article-title":"HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica","volume":"18","author":"Asgari","year":"2012","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0020","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4049\/jimmunol.170.2.711","article-title":"Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses","volume":"170","author":"Bennett","year":"2003","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2017.02.006_bb0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/art.24227","article-title":"Genetic, immunologic, and immunohistochemical analysis of the programmed death 1\/programmed death ligand 1 pathway in human systemic lupus erythematosus","volume":"60","author":"Bertsias","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00262-004-0593-x","article-title":"Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy","volume":"54","author":"Blank","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0035","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4049\/jimmunol.170.3.1257","article-title":"Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production","volume":"170","author":"Brown","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jneuroim.2006.10.006","article-title":"PD-1\/PD-L1, but not PD-1\/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis","volume":"182","author":"Carter","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09273940802491884","article-title":"Constitutive neuronal expression of the immune regulator, programmed death 1 (PD-1), identified during experimental autoimmune uveitis","volume":"17","author":"Chen","year":"2009","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2007.01.012","article-title":"The PD-1\/PD-L pathway is upregulated during IL-12-induced suppression of EAE mediated by IFN-gamma","volume":"185","author":"Cheng","year":"2007","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.jneuroim.2017.02.006_bb0055","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/EJE-09-0600","article-title":"Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 JO31 and CT60 gene polymorphisms","volume":"161","author":"Daroszewski","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0060","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1002\/art.20436","article-title":"Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects","volume":"50","author":"Ferreiros-Vidal","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0065","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0070","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10038-007-0145-2","article-title":"Failure to confirm association between PDCD1 polymorphisms and rheumatoid arthritis in a Japanese population","volume":"52","author":"Iwamoto","year":"2007","journal-title":"J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.jneuroim.2017.02.006_bb0075","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-065X.2012.01136.x","article-title":"Immune checkpoints in CNS autoimmunity","volume":"248","author":"Joller","year":"2012","journal-title":"Immunol. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2017.02.006_bb0080","first-page":"787","article-title":"The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease","volume":"128","author":"Karabon","year":"2009","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.jneuroim.2017.02.006_bb0085","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/art.20966","article-title":"A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese","volume":"52","author":"Kong","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jneuroim.2017.02.006_bb0090","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/art.27417","article-title":"Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus","volume":"62","author":"Kristjansdottir","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ana.20514","article-title":"A PD-1 polymorphism is associated with disease progression in multiple sclerosis","volume":"58","author":"Kroner","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0100","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0105","series-title":"McAlpine's Multiple Sclerosis","first-page":"323","article-title":"Pathology of multiple sclerosis","volume":"3","author":"Lassmann","year":"1998"},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0110","doi-asserted-by":"crossref","first-page":"10691","DOI":"10.1073\/pnas.0307252101","article-title":"PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells","volume":"101","author":"Latchman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0115","doi-asserted-by":"crossref","first-page":"R163","DOI":"10.1186\/ar2071","article-title":"Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population","volume":"8","author":"Lee","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0120","first-page":"230","article-title":"Meta-analysis of genetic polymorphisms in programmed cell death 1","volume":"74","author":"Lee","year":"2014","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0125","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/art.20040","article-title":"Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus","volume":"50","author":"Lin","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00296-009-1264-1","article-title":"Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population","volume":"31","author":"Liu","year":"2011","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0135","doi-asserted-by":"crossref","first-page":"247637","DOI":"10.1155\/2014\/247637","article-title":"A promoter region polymorphism in PDCD-1 gene is associated with risk of rheumatoid arthritis in the Han Chinese population of Southeastern China","volume":"2014","author":"Liu","year":"2014","journal-title":"Int. J. Genomics."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0140","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jneuroim.2017.02.006_bb0145","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis. The 2013 revision","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0155","doi-asserted-by":"crossref","first-page":"817238","DOI":"10.1155\/2015\/817238","article-title":"Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review","volume":"2015","author":"McKay","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"3","key":"10.1016\/j.jneuroim.2017.02.006_bb0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.diabres.2008.12.003","article-title":"Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes","volume":"83","author":"Momin","year":"2009","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0165","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2265.2007.02848.x","article-title":"Tag SNP screening of the PDCD1 gene for association with Graves' disease","volume":"67","author":"Newby","year":"2007","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.02.006_bb0170","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00439-006-0309-8","article-title":"PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children","volume":"121","author":"Ni","year":"2007","journal-title":"Hum. Genet."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0175","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1399-0039.2003.00136.x","article-title":"Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes","volume":"62","author":"Nielsen","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0180","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ni1165","article-title":"Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4","volume":"6","author":"Probst","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0185","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ng1020","article-title":"A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans","volume":"32","author":"Prokunina","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0190","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/art.20280","article-title":"Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope","volume":"50","author":"Prokunina","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0195","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple sclerosis severity score. Using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jneuroim.2007.09.019","article-title":"Programmed death-1: from gene to protein in autoimmune human myasthenia gravis","volume":"193","author":"Sakthivel","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0205","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.20022119","article-title":"Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis","volume":"198","author":"Salama","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0210","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00439-004-1172-0","article-title":"Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies","volume":"115","author":"Sanghera","year":"2004","journal-title":"Hum. Genet."},{"issue":"5","key":"10.1016\/j.jneuroim.2017.02.006_bb0215","first-page":"763","article-title":"Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients","volume":"29","author":"Tahoori","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0220","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.gene.6364383","article-title":"Association of PDCD1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort","volume":"8","author":"Thorburn","year":"2007","journal-title":"Genes Immun."},{"issue":"3","key":"10.1016\/j.jneuroim.2017.02.006_bb0225","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00415-009-0039-7","article-title":"Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities","volume":"256","author":"Tremlett","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0230","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.ejhg.5201767","article-title":"Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus","volume":"15","author":"Velazquez-Cruz","year":"2007","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0235","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/intimm\/dxp072","article-title":"PD1 blockade reverses the suppression of melanoma antigenspecific CTL by CD4+ CD25(Hi) regulatory T cells","volume":"21","author":"Wang","year":"2009","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0240","doi-asserted-by":"crossref","first-page":"W600","DOI":"10.1093\/nar\/gkp290","article-title":"SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies","volume":"37","author":"Xu","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.jneuroim.2017.02.006_bb0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00776-014-0648-6","article-title":"The programmed cell death 1 gene polymorphisms (PD 1.3G\/A, PD 1.5 C\/T and PD 1.9 C\/T) and susceptibility to ankylosing spondylitis: a meta-analysis","volume":"20","author":"Yang","year":"2015","journal-title":"J. Orthop. Sci."},{"key":"10.1016\/j.jneuroim.2017.02.006_bb0250","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/intimm\/dxh121","article-title":"Suppression of expression and function of negative immune regulator PD-1 by certain pattern recognition and cytokine receptor signals associated with immune system danger","volume":"16","author":"Zhong","year":"2004","journal-title":"Int. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816303162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816303162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:29:41Z","timestamp":1759048181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572816303162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":50,"alternative-id":["S0165572816303162"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.02.006","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}